FDA Rejection Of Avastin For Breast Cancer Therapy Would Be ‘Unscientific, Unethical,’ Editorial Says
It would “not only be unscientific but unethical” for FDA to reject Genentech’s colon and lung cancer treatment Avastin for use as metastatic breast cancer treatment, a
More: continued here